scispace - formally typeset
D

Dezhong Zhou

Researcher at Xi'an Jiaotong University

Publications -  73
Citations -  2589

Dezhong Zhou is an academic researcher from Xi'an Jiaotong University. The author has contributed to research in topics: Gene delivery & Transfection. The author has an hindex of 27, co-authored 63 publications receiving 1759 citations. Previous affiliations of Dezhong Zhou include Tianjin University & Nankai University.

Papers
More filters
Journal ArticleDOI

A hybrid injectable hydrogel from hyperbranched PEG macromer as a stem cell delivery and retention platform for diabetic wound healing.

TL;DR: A new injectable hydrogel system was fabricated from hyperbranched multi-acrylated poly(ethylene glycol) macromers (HP-PEGs) and thiolated hyaluronic acid (HA-SH) and used as a stem cell delivery and retention platform and may be a promising candidate for diabetic wound treatment.
Journal ArticleDOI

Thermodynamic Understanding of Li-Dendrite Formation

TL;DR: In this paper, the authors take these two key factors as an example to emphasize the importance of thermodynamic understandings of the Li-dendrite issue and discuss the key challenges and corresponding strategies for designing advanced dendrite-free Li-metal anodes with respect to thermodynamic factors.
Journal ArticleDOI

The transition from linear to highly branched poly(β-amino ester)s: Branching matters for gene delivery

TL;DR: The findings prove that the A2 + B3 + C2 approach is highly generalizable and flexible for the design and synthesis of HPAEs, which cannot be achieved by the conventional polymerization approach; H PAEs are more efficient vectors in gene transfection than the corresponding LPAEs.
Journal ArticleDOI

Bioreducible Zinc(II)-Coordinative Polyethylenimine with Low Molecular Weight for Robust Gene Delivery of Primary and Stem Cells

TL;DR: The design and synthesis of a dipicolylamine-based disulfide-containing zinc(II) coordinative module (Zn-DDAC), which is used to functionalize LMW PEI to give a non-viral vector with high efficiency and safety in primary and stem cells, demonstrate great promise for the development of next-generation non-Viral vectors for clinically viable gene therapy.